Abstract
Abuse of drugs is correlated with various medical, behavioral, psychological, spiritual, financial, social, family, and legal concerns and profoundly impact the people involved, their families, and society. Drugs of abuse (DOA) testing in biological specimens may provide objective information on the usage or misuse of drugs by the person involved and thus it is considered as one of the main tasks in the different disciplines of forensic toxicology and related areas. Testing is carried out for two primary reasons. The first is to test for or prove an alleged acute drug effect or intoxication/poisoning. The second is monitoring abstinence from DOA, e.g., in workplace drug testing.
This chapter deals with the types and methods of analysis for DOA testing that focus on trends and developments in the last decade regarding relevant analytes and analytical methodology. The authors often rely on alternative matrices for monitoring DOAs.
References
Aacc.org (2021) Developing standards for oral fluid as an alternative matrix for toxicology testing. AACC.org. Available https://www.aacc.org/cln/articles/2017/november/developing-standards-for-oral-fluid-as-an-alternative-matrix-for-toxicology-testing. Accessed 1 March 2021
Abdallah IA, Hammell DC, Stinchcomb AL, Hassan HE (2016) A fully validated LC–MS/MS method for simultaneous determination of nicotine and its metabolite cotinine in human serum and its application to a pharmacokinetic study after using nicotine transdermal delivery systems with standard heat application in adult smokers. J Chromatogr B 1020:67–77
Abubakar II, Tillmann T, Banerjee A (2015) Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385(9963):117–171
Agius R, Nadulski T, Kahl HG, Dufaux B (2012) Significantly increased detection rate of drugs of abuse in urine following the introduction of new German driving licence regranting guidelines. Forensic Sci Int 215(1-3):32–37
Ammann J, McLaren JM, Gerostamoulos D, Beyer J (2012) Detection and quantification of new designer drugs in human blood: part 1–synthetic cannabinoids. J Anal Toxicol 36(6):372–380
Australian/New Zealand Specialist Advisory Group in Toxicology (2012) MS identification guidelines in forensic toxicology – an Australian approach. TIAFT Bull 42(2):52–55
Baumgartner MR (2014) Nails: an adequate alternative matrix in forensic toxicology for drug analysis? Bioanalysis 6(17):2189–2191
Baumgartner MR, Guglielmello R, Fanger M, Kraemer T (2012) Analysis of drugs of abuse in hair: evaluation of the immunochemical method VMA-T vs. LC–MS/MS or GC–MS. Forensic Sci Int 215(1-3):56–59
Blencowe T, Pehrsson A, Lillsunde P, Vimpari K, Houwing S, Smink B, Verstraete A (2011) An analytical evaluation of eight on-site oral fluid drug screening devices using laboratory confirmation results from oral fluid. Forensic Sci Int 208(1-3):173–179
Bogusz MJ (1999) Hyphenated liquid chromatographic techniques in forensic toxicology. J Chromatogr B Biomed Sci Appl 733(1-2):65–91
Bogusz MJ, Maier RD, Erkens M, Driessen S (1997) Determination of morphine and its 3-and 6-glucuronides, codeine, codeine-glucuronide and 6-monoacetylmorphine in body fluids by liquid chromatography atmospheric pressure chemical ionization mass spectrometry. J Chromatogr B Biomed Sci Appl 703(1-2):115–127
Bogusz MJ, Maier RD, Krüger KD, Kohls U (1998) Determination of common drugs of abuse in body fluids using one isolation procedure and liquid chromatography-atmospheric-pressure chemical-ionization mass spectrometry. J Anal Toxicol 22(7):549–558
Bogusz MJ, Maier RD, Erkens M, Kohls U (2001) Detection of non-prescription heroin markers in urine with liquid chromatography—atmospheric pressure chemical ionization mass spectrometry. J Anal Toxicol 25(6):431–438
Bosker WM, Huestis MA (2009) Oral fluid testing for drugs of abuse. Clin Chem 55(11):1910–1931
Caplan YH, Goldberger BA (2001) Alternative specimens for workplace drug testing. J Anal Toxicol 25(5):396–399
CDPHE (Colorado Department of Public Health and Environment) (2016) 2016 medical marijuana registry statistics. https://www.colorado.gov/pacific/cdphe/2016-medical-marijuana-registry-statistics
Chèze M, Duffort G, Deveaux M, Pépin G (2005) Hair analysis by liquid chromatography–tandem mass spectrometry in toxicological investigation of drug-facilitated crimes: report of 128 cases over the period June 2003–May 2004 in metropolitan Paris. Forensic Sci Int 153(1):3–10
Choo RE, Murphy CM, Jones HE, Huestis MA (2005) Determination of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, 2-ethyl-5-methyl-3, 3-diphenylpyraline and methadol in meconium by liquid chromatography atmospheric pressure chemical ionization tandem mass spectrometry. J Chromatogr B 814(2):369–373
Concheiro M, de Castro A, Quintela O, Cruz A, Lopez-Rivadulla M (2004) Chromatogr B 810:319
Concheiro M, Simoes SMDSS, Quintela O, de Castro A, Dias MJR, Cruz A, López-Rivadulla M (2007) Fast LC–MS/MS method for the determination of amphetamine, methamphetamine, MDA, MDMA, MDEA, MBDB and PMA in urine. Forensic Sci Int 171(1):44–51
Cone EJ (1997) New developments in biological measures of drug prevalence. NIDA Res Monogr 167:108–129
Dams R, Murphy CM, Lambert WE, Huestis MA (2003) Urine drug testing for opioids, cocaine, and metabolites by direct injection liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 17(14):1665–1670
Dams R, Choo RE, Lambert WE, Jones H, Huestis MA (2007) Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients. Drug Alcohol Depend 87(2-3):258–267
Dasgupta A (2007) Handbook of drug monitoring methods: therapeutics and drugs of abuse. Springer, New York
Dolan K, Rouen D, Kimber JO (2004) An overview of the use of urine, hair, sweat and saliva to detect drug use. Drug Alcohol Rev 23(2):213–217
Dolder PC, Liechti ME, Rentsch KM (2018) Development and validation of an LC-MS/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial. J Clin Lab Anal 32(2):e22265
Drummer OH (2004) Postmortem toxicology of drugs of abuse. Forensic Sci Int 142(2-3):101–113
Drummer OH (2006) Drug testing in oral fluid. Clin Biochem Rev 27(3):147
Eichhorst JC, Etter ML, Rousseaux N, Lehotay DC (2009) Drugs of abuse testing by tandem mass spectrometry: a rapid, simple method to replace immunoassays. Clin Biochem 42(15):1531–1542
EMCDDA (2016) Information on the high-risk drug use (HRDU) (formerly ‘problem drug use’ (PDU)) key indicator. emcdda.europa.eu. Accessed 27 September 2016
Fucci N, De Giovanni N, De Giorgio F, Liddi R, Chiarotti M (2006) An evaluation of the Cozart® RapiScan system as an on-site screening tool for drugs of abuse in a non-conventional biological matrix: vitreous humor. Forensic Sci Int 156(2-3):102–105
Garg U, Ferguson AM (2012) Alternate specimens for drugs-of-abuse testing: preanalytical and interpretative considerations. In: Barbarajean M, Bissell MG, Kwong TC, Wu AHB (eds) Clinical toxicology testing: a guide for laboratory professionals. CAP Press, Durham, pp 71–80
Garside D (2008) Drugs-of-abuse in nails. In: Drug testing in alternate biological specimens. Humana Press, New York, pp 43–65
Gjerde H, Verstraete A (2010) Can the prevalence of high blood drug concentrations in a population be estimated by analyzing oral fluid? A study of tetrahydrocannabinol and amphetamine. Forensic Sci Int 195(1-3):153–159
Gjerde H, Verstraete AG (2011) Estimating equivalent cut-off thresholds for drugs in blood and oral fluid using prevalence regression: a study of tetrahydrocannabinol and amphetamine. Forensic Sci Int 212(1-3):e26–e30
Goggin MM, Janis GC (2019) Salt-assisted liquid-liquid extraction of meconium for analysis of cocaine and amphetamines by liquid chromatography-tandem mass spectrometry. In: LC-MS in drug analysis. Humana Press, New York
Guthrie R, Susi A (1963) A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 32(3):338–343
Hadland SE, Levy S (2016) Objective testing: urine and other drug tests. Child Adolesc Psychiatr Clin 25(3):549–565
Hancock JR, D’Agostino PA, Chenier CL (2005) Presented at the 3rd conference on mass spectrometry applied to chemical and biological warfare agents, Noordwijkerhout, The Netherlands, 17–20 April 2005
Holmgren P, Druid H, Holmgren A, Ahlner J (2004) Stability of drugs in stored postmortem femoral blood and vitreous humor. J For Sci 49(4):1–6
Jaffee WB, Trucco E, Levy S, Weiss RD (2007) Is this urine really negative? A systematic review of tampering methods in urine drug screening and testing. J Subst Abus Treat 33(1):33–42
Janda I, Weinmann W, Kuehnle T, Lahode M, Alt A (2002) Determination of ethyl glucuronide in human hair by SPE and LC–MS/MS. Forensic Sci Int 128(1-2):59–65
Jang M, Kim J, Han I, Yang W (2015) Simultaneous determination of LSD and 2-oxo-3-hydroxy LSD in hair and urine by LC–MS/MS and its application to forensic cases. J Pharm Biomed Anal 115:138–143
Jantos R, Veldstra JL, Mattern R, Brookhuis KA, Skopp G (2011) Analysis of 3,4-methylenedioxymetamphetamine: whole blood versus dried blood spots. J Anal Toxicol 35(5):269–273
Jeanville PM, Woods JH, Baird TJ III, Estapé ES (2000) Direct determination of ecgonine methyl ester and cocaine in rat plasma, utilizing online sample extraction coupled with rapid chromatography/quadrupole orthogonal acceleration time-of-flight detection. J Pharm Biomed Anal 23(5):897–907
Jensen TL, Wu F, McMillin GA (2019) Detection of in utero exposure to Cannabis in paired umbilical cord tissue and meconium by liquid chromatography-tandem mass spectrometry. Clin Mass Spectrometry 14:115–123
Katagi M, Nishikawa M, Tatsuno M, Miyazawa T, Tsuchihashi H, Suzuki A, Shirota O (1998) Direct analysis of methamphetamine and amphatamine enantiomers in human urine by semi-microcolumn HPLC: electrospray ionization mass spectrometry. Eisei Kagaku 44(2):107–115
Katagi M, Tatsuno M, Miki A, Nishikawa M, Tsuchihashi H (2000) Discrimination of dimethylamphetamine and methamphetamine use: simultaneous determination of dimethylamphetamine-N-oxide and other metabolites in urine by high-performance liquid chromatography-electrospray ionization mass spectrometry. J Anal Toxicol 24(5):354–358
Katagi M, Nishikawa M, Tatsuno M, Miki A, Tsuchihashi H (2001) Column-switching high-performance liquid chromatography–electrospray ionization mass spectrometry for identification of heroin metabolites in human urine. J Chromatogr B Biomed Sci Appl 751(1):177–185
Kumar S, Wahid A, Anoop KV (2012) Physiology and anatomy of hair in drug abusing cases. IJMTFM 2:153–159
Lua IA, Lin SL, Lin HR, Lua AC (2012) Replacing immunoassays for mephedrone, ketamines and six amphetamine-type stimulants with flow injection analysis tandem mass spectrometry. J Anal Toxicol 36(8):575–581
Moeller KE, Lee KC, Kissack JC (2008) Urine drug screening: practical guide for clinicians. In: Mayo clinic proceedings, vol 83. Elsevier, Amsterdam, pp 66–76
Musshoff F, Madea B (2007) Analytical pitfalls in hair testing. Anal Bioanal Chem 388(7):1475–1494
Musshoff F, Kirschbaum KM, Graumann K, Herzfeld C, Sachs H, Madea B (2012) Evaluation of two immunoassay procedures for drug testing in hair samples. Forensic Sci Int 215(1-3):60–63
National Center on Substance Abuse and Child Welfare/Substance Abuse and Mental Health Services Administration (2015) Drug testing practice guidelines. Available https://ncsacw.samhsa.gov/files/IA_Drug_Testing_Bench_Card_508.pdf
Nishikawa M, Nakajima K, Tatsuno M, Kasuya F, Igarashi K, Fukui M, Tsuchihashi H (1994) The analysis of cocaine and its metabolites by liquid chromatography/atmospheric pressure chemical ionization-mass spectrometry (LC/APCI-MS). Forensic Sci Int 66(3):149–158
Patel KN, Patel JK, Patel MP, Rajput GC, Patel HA (2010) Introduction to hyphenated techniques and their applications in pharmacy. Pharm Methods 1(1):2–13
Paul LD, Musshoff F, Aebi B, Auwärter V, Krämer T, Peters F, Schmitt G (2009) Richtlinie der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen. Toxichem Krimtech 76(3):142–176
Pelander A, Ristimaa J, Ojanperä I (2010) Vitreous humor as an alternative matrix for comprehensive drug screening in postmortem toxicology by liquid chromatography-time-of-flight mass spectrometry. J Anal Toxicol 34(6):312–318
Peters FT, Schaefer S, Staack RF, Kraemer T, Maurer HH (2003) Screening for and validated quantification of amphetamines and of amphetamine-and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. J Mass Spectrom 38(6):659–676
Pujol ML, Cirimele V, Tritsch PJ, Villain M, Kintz P (2007) Evaluation of the IDS One-Step™ ELISA kits for the detection of illicit drugs in hair. Forensic Sci Int 170(2-3):189–192
Quest Diagnostics (n.d.) Common drugs of abuse. https://www.questdiagnostics.com/home/companies/employer/drug-screening/drugs-tested/
Rapinoja M-L, Kuitunen M-L, Bjork H, Rosendahl K, Vanninen P (2005) Presented at the 3rd conference on mass spectrometry applied to chemical and biological warfare agents, Noordwijkerhout, The Netherlands, 17–20 April 2005
Ristimaa J, Gergov M, Pelander A, Halmesmäki E, Ojanperä I (2010) Broad-spectrum drug screening of meconium by liquid chromatography with tandem mass spectrometry and time-of-flight mass spectrometry. Anal Bioanal Chem 398(2):925–935
SAMHSA (2020) Retrieved 24 June 2020. https://www.samhsa.gov/sites/default/files/workplace/2010GuidelinesAnalytesCutoffs.pdf
Saussereau E, Lacroix C, Gaulier JM, Goulle JP (2012) Online liquid chromatography/tandem mass spectrometry simultaneous determination of opiates, cocainics and amphetamines in dried blood spots. J Chromatogr B 885:1–7
Schänzle G, Li S, Mikus G, Hofmann U (1999) Rapid, highly sensitive method for the determination of morphine and its metabolites in body fluids by liquid chromatography–mass spectrometry. J Chromatogr B Biomed Sci Appl 721(1):55–65
Schubert W, Mattern R (2009) Urteilsbildung in der medizinisch-psychologischen Fahreignungsdiagnostik–Beurteilungskriterien. Kirschbaum, Bonn
Segura J, Ventura R, Jurado C (1998) Derivatization procedures for gas chromatographic–mass spectrometric determination of xenobiotics in biological samples, with special attention to drugs of abuse and doping agents. J Chromatogr B Biomed Sci Appl 713(1):61–90
United Nations (2012) World drug report 2012 (PDF). Retrieved 27 September 2016.
Vindenes V, Yttredal B, Øiestad EL, Waal H, Bernard JP, Mørland JG, Christophersen AS (2011) Oral fluid is a viable alternative for monitoring drug abuse: detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with methadone or buprenorphine. J Anal Toxicol 35(1):32–39
Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, Coggeshall M (2016) Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388(10053):1459–1544
Welch MJ, Sniegoski LT, Tai S (2003) Two new standard reference materials for the determination of drugs of abuse in human hair. Anal Bioanal Chem 376(8):1205–1211
Wille SM, Raes E, Lillsunde P, Gunnar T, Laloup M, Samyn N, Verstraete AG (2009) Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs. Ther Drug Monit 31(4):511–519
Wilson ID, Brinkman UT (2003) Hyphenation and hypernation: the practice and prospects of multiple hyphenation. J Chromatogr A 1000(1-2):325–356
Wohlfarth A, Weinmann W, Dresen S (2010) LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum. Anal Bioanal Chem 396(7):2403–2414
Wood M, Laloup M, Samyn N, Fernandez MDMR, de Bruijn EA, Maes RA, De Boeck G (2006) Recent applications of liquid chromatography–mass spectrometry in forensic science. J Chromatogr A 1130(1):3–15
World Health Organization (2004) Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention: WHO/UNODC/UNAIDS position paper. WHO, Geneva
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kumar, S. (2023). Drugs of Abuse: Trends and Advanced Analytical Methods. In: Shrivastava, P., Lorente, J.A., Srivastava, A., Badiye, A., Kapoor, N. (eds) Textbook of Forensic Science . Springer, Singapore. https://doi.org/10.1007/978-981-99-1377-0_24
Download citation
DOI: https://doi.org/10.1007/978-981-99-1377-0_24
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-1376-3
Online ISBN: 978-981-99-1377-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)